Studies have found that individuals with AD have alterations in the levels of amyloid beta (Aβ), total tau (t‐tau), and phosphorylated tau (p‐tau) proteins in cerebrospinal fluid (CSF) and plasma. Here, MAPT is linked to Alzheimer disease.